Dianthus Therapeutics (DNTH) Total Liabilities (2017 - 2025)

Dianthus Therapeutics' Total Liabilities history runs 9 years deep, the most recent figure standing at $37.5 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 74.27% year-over-year to $37.5 million; the TTM figure through Dec 2025 stood at $37.5 million (up 74.27% YoY), while the FY2025 annual figure was $37.5 million, up 74.27% from the prior year.
• Total Liabilities was $37.5 million for Q4 2025 at Dianthus Therapeutics, up from $31.0 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $43.2 million in Q1 2022 to a low of $4.0 million in Q2 2023.
• Historically, Total Liabilities has averaged $20.2 million across 5 years, with a median of $16.9 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities soared 177.6% in 2022, then sank 89.77% in 2023.
• A 5-year view of Total Liabilities shows it stood at $17.3 million in 2021, then sank by 45.23% to $9.5 million in 2022, then advanced by 11.43% to $10.5 million in 2023, then jumped by 104.38% to $21.5 million in 2024, then surged by 74.27% to $37.5 million in 2025.
• The last three Total Liabilities figures came in at $37.5 million (Q4 2025), $31.0 million (Q3 2025), and $23.0 million (Q2 2025), per Business Quant data.